日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Super-Response to Guselkumab Treatment in Patients With Moderate-to-Severe Psoriasis: Real-World Data With Up to Five Years of Follow-Up in The Czech Republic

捷克共和国中重度银屑病患者对古塞库单抗治疗的超强反应：长达五年随访的真实世界数据

期刊:International Journal of Dermatology
影响因子:3.2
doi:10.1111/ijd.70126
Kojanova, Martina; Pejrilova, Daniela; Fialova, Jorga; Cetkovska, Petra; Gkalpakiotis, Spyridon; Machovcova, Alena; Arenberger, Petr; Stork, Jiri; Dolezal, Tomas; Tichy, Martin
银屑病
发表日期：2026
文献求助 收藏

Real-World Data on Brodalumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: An Observational Study from the Czech Republic BIOREP Registry

来自捷克共和国 BIOREP 注册研究的 Brodalumab 治疗中重度斑块状银屑病患者的真实世界数据：一项观察性研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-02952-4
Kojanova, Martina; Turkova, Barbora; Gkalpakiotis, Spyridon; Cetkovska, Petra; Fialova, Jorga; Dolezal, Tomas; Machovcova, Alena; Apol, Eydna Didriksen
银屑病
发表日期：2024
文献求助 收藏

Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic

Risankizumab治疗中重度银屑病：来自捷克共和国的真实世界多中心经验

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-021-00556-2
Gkalpakiotis, Spyridon; Cetkovska, Petra; Arenberger, Petr; Dolezal, Tomas; Arenbergerova, Monika; Velackova, Barbora; Fialova, Jorga; Kojanova, Martina
银屑病
发表日期：2021
文献求助 收藏